Resources
High Content Analysis of 2D and 3D cellular models for target and phenotypic drug discovery
Lachize, et al
Courtesy of Charles River
ioGlutamatergic Neurons flyer
bit.bio
Optimized reprogramming of human iPSCs to generate distinct neuronal subtypes
Karim, et al
bit.bio
Accelerating in vitro target and drug discovery using reprogrammed glutamatergic neurons
Dr Shushant Jain, Group Leader
In Vitro Biology
Charles River at SLAS
Advances in cellular reprogramming: from stem cells to printed tissues
Prof Hagan Bayley, University of Oxford
Dr Mark Kotter, Founder and CEO bit.bio
bit.bio
Molecular and functional characterization of stem cells-derived glutamatergic neurons in support of drug discovery applications
Iovino, et al
Courtesy of Charles River